India’s science problem is not talent, but priorities

India's science challenge lies not in a lack of talent, but in priorities, according to a recent analysis. The country's scientific workforce is vast, yet it rarely produces groundbreaking scientific achievements. The root cause appears to be a misalignment between research priorities and funding mechanisms. While developed nations like the United States, Germany, Japan, and South Korea allocate significant portions of their GDP to research and development, India spends merely 0.64 percent.

However, the most striking statistic is the source of funding. In India, business contributes around 40 percent of R&D expenditure, compared to roughly three-quarters in the US and China. This imbalance creates both a scale and private-sector participation gap in India's research ecosystem. Moreover, there is mounting pressure on scientists to translate their findings into commercially viable products, which detracts from time spent on fundamental research.

Basic science, the foundation for innovation, needs a reevaluation. The first step is to allocate a protected funding window for investigator-driven, curiosity-led research that doesn't require immediate patent or product promises. Second, research funding should be divided into discovery, translation, and deployment portfolios, each with distinct timelines and success metrics.

Third, India should invest in long-duration funding with rigorous scientific review but less administrative micromanagement. Fourth, a national shared research infrastructure should be established, providing access to advanced platforms like genomics, proteomics, and AI across institutions. Lastly, there is a need to change how research and scientists are evaluated.

Metrics like publication counts and journal impact factors are convenient but don't necessarily measure discovery. Instead, scientific assessment should reward originality, reproducibility, important questions, new knowledge, datasets, platforms, technologies, and influence on science or health policy. To illustrate the potential, China's experience serves as a case study.

As its R&D investment has grown, it has become a major global supplier of affordable technology, producing a significant portion of the world's solar PV modules, battery cells, and electric vehicles. The key takeaway is that connecting discovery to engineering, manufacturing, and markets is crucial. India possesses a unique natural advantage: its diverse population offers a vast setting for research.

The goal should be to create an ecosystem that attracts young scientists willing to pursue unconventional questions for years, fail, change direction, and try again without being penalized for not producing immediate products. Ultimately, India aims to build a research system capable of producing Nobel-level discoveries, rather than merely targeting the Nobel Prize itself.